Bacteria

Astarte Medical and Tiny Health Join Forces to Optimize Gut Health for Vulnerable Preterm Infants

Retrieved on: 
Thursday, September 21, 2023

YARDLEY, Pa. and AUSTIN, Texas, Sept. 21, 2023 /PRNewswire-PRWeb/ -- Astarte Medical, a leading pediatric clinical intelligence company, is forming a joint venture with Tiny Health, makers of gut microbiome tests for babies and expecting parents. The partners have agreed to develop a clinical-facing technology solution to support gut health for preterm and critically ill infants receiving care in the neonatal ICU.

Key Points: 
  • The partners have agreed to develop a clinical-facing technology solution to support gut health for preterm and critically ill infants receiving care in the neonatal ICU.
  • "By partnering with Astarte Medical, we're extending our solution to support infants and families at their most vulnerable time.
  • In a previous multi-center microbiome study, Astarte Medical identified six gut community types among nearly 300 preterm infants born under 34 weeks gestational age.
  • Tiny Health will offer NICU parents the option to test their infants post-discharge to extend the understanding of the maturity patterns of infants born preterm.

Study Details Immune Cells Vital to Success of Vaccines against Coronavirus

Retrieved on: 
Thursday, September 21, 2023

NEW YORK, Sept. 21, 2023 /PRNewswire/ -- A study has revealed new details about a key population of immune system cells critical to successful vaccination against the pandemic virus, SARS-CoV-2.

Key Points: 
  • A subset of T cells, labeled with the surface protein CD8, produce molecules that directly kill infected cells.
  • B cells produce antibody proteins that neutralize and label infected cells for removal from the body.
  • The mRNA vaccines deployed against COVID-19 were based on RNA, a genetic material used to encode the spike protein that the virus needs to attach to human cells.
  • "Although our study looks at mRNA vaccination against coronavirus, the antigen-specific CD8+ T cell subpopulations we uncover represent key features of immune responses more broadly, and may help us to study T cells in other disease settings."

Asthma Canada and Fellowes Canada Announces Partnership in Support of Community Health

Retrieved on: 
Thursday, September 21, 2023

TORONTO, Sept. 21, 2023 /CNW/ - Asthma Canada; as a leading national health organization dedicated to improving the lives of Canadians affected by asthma and allergies, are pleased to announce a crucial partnership aimed at enhancing community health and well-being.

Key Points: 
  • TORONTO, Sept. 21, 2023 /CNW/ - Asthma Canada; as a leading national health organization dedicated to improving the lives of Canadians affected by asthma and allergies, are pleased to announce a crucial partnership aimed at enhancing community health and well-being.
  • Inclusivity and Support: Asthma Canada and Fellowes are committed to reaching those who are most vulnerable within our communities.
  • Asthma Canada remains deeply committed to its mission of enhancing the quality of life for Canadians living with asthma and allergies.
  • For more information about Asthma Canada and the air purifiers donated by Fellowes, please visit https://asthma.ca/fellowes

Latest Clinical Evidence Presented at APWCA's Wound Week™ 2023 Illustrates the Significant and New Clinical Utility of the MolecuLight Point-of-Care Imaging Platform

Retrieved on: 
Thursday, September 21, 2023

Wound Week is a leading multidisciplinary meeting of wound care professionals that presents cutting-edge clinical findings and best practices presented by its expert faculty.

Key Points: 
  • Wound Week is a leading multidisciplinary meeting of wound care professionals that presents cutting-edge clinical findings and best practices presented by its expert faculty.
  • "The evidence is irrefutable," says Dr. Thomas Serena, the Founder and Medical Director of The SerenaGroup®.
  • "We are thrilled with the significant additional clinical evidence being presented at Wound Week 2023 showing the impressive results derived from MolecuLight point-of-care devices," says Anil Amlani, MolecuLight's CEO.
  • "The clinical insights that are informed by the MolecuLight platform span the wound care continuum, including wound hygiene, wound bed preparation, antimicrobial stewardship, and patient engagement (through the incorporation of MolecuLight).

Clafin University Student Receives SBB Research Group Foundation STEM Scholarship

Retrieved on: 
Tuesday, September 19, 2023

CHICAGO, Sept. 19, 2023 /PRNewswire-PRWeb/ -- The SBB Research Group Foundation named Nickeisha Cuthbert a recipient of its STEM scholarship. The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).

Key Points: 
  • CHICAGO, Sept. 19, 2023 /PRNewswire-PRWeb/ -- The SBB Research Group Foundation named Nickeisha Cuthbert a recipient of its STEM scholarship.
  • The $2,500 award empowers students to create value for society by pursuing higher learning through interdisciplinary combinations of Science, Technology, Engineering, and Mathematics (STEM).
  • I'm so excited we could support her through this scholarship," said Matt Aven, co-founder and board member of the SBB Research Group Foundation.
  • For eligibility criteria and more information on the Foundation's STEM scholarship, please visit http://www.sbbscholarship.org .

Bronopol's Biocidal Effectiveness Boosts Demand Across Industries, Catapulting the Market to 2028

Retrieved on: 
Tuesday, September 19, 2023

DUBLIN, Sept. 18, 2023 /PRNewswire/ -- The global bronopol market, which reached a size of US$ 1.1 billion in 2022, is poised for substantial growth, with projections indicating it will reach US$ 1.5 billion by 2028. This growth is expected to be driven by factors such as increasing demand for drinkable water, the biocidal properties of bronopol, and its diverse applications in various industries.

Key Points: 
  • This growth is expected to be driven by factors such as increasing demand for drinkable water, the biocidal properties of bronopol, and its diverse applications in various industries.
  • It is available as crystals or crystalline powder, typically in white or pale yellow shades depending on iron content.
  • How has the global bronopol market performed to date, and what are the growth prospects in the coming years?
  • Who are the key players in the global bronopol market, and what is the competitive landscape?

Mojave Raises $12.5M from Fifth Wall, At One Ventures, Xerox Ventures to Change the Nature of Air Conditioning

Retrieved on: 
Monday, September 18, 2023

SUNNYVALE, Calif., Sept. 18, 2023 /PRNewswire/ -- Today, Mojave Energy Systems announces its $12.5 million seed round of funding that will be used to launch its third-generation liquid desiccant air conditioning platform.

Key Points: 
  • The novel Mojave product cuts in half the energy required to provide buildings with fresh, cool, and dry outdoor air.
  • The round is co-led by At One Ventures and Fifth Wall with participation from Xerox Ventures and others.
  • "Today the story is about dehumidification, not cooling; in fact, we spend more energy dehumidifying air than we do cooling it.
  • The biocidal properties of its liquid desiccant even purify the air from bacteria and viruses further improving air quality.

Resistance to antibiotics in northern Nigeria: what bacteria are prevalent, and which drugs work against them

Retrieved on: 
Sunday, September 17, 2023

Antimicrobial resistance – the ability of microorganisms to resist drugs that have been developed to control them – is a severe problem in African countries.

Key Points: 
  • Antimicrobial resistance – the ability of microorganisms to resist drugs that have been developed to control them – is a severe problem in African countries.
  • The continent has the highest global burden of antimicrobial-resistant infections, with 114.8 deaths per 100,000 people.
  • Physicians need laboratory data to choose the right antibiotic, at the right dose, for the right period of time.
  • This can lead to choosing ineffective antibiotics, which can lead to increases in resistant bacteria.
  • In other words, to develop a list of what bacteria are prevalent in the region and which drugs work against them.
  • To accomplish this, we recently conducted a study of multidrug-resistant bacteria obtained from patients in six hospitals in northern Nigeria.

Drug-resistant bacteria in Nigeria

    • We chose to analyse bacteria that are resistant to more than one drug because they are the biggest challenge when treating infections.
    • We found that about 85% of the bacteria isolated from infections were resistant to the most commonly used antibiotics.
    • The good news was that two antibiotics, tigecycline and fosfomycin, remained very active even against highly resistant strains of bacteria.

Genetic mechanisms

    • This was done to understand what made these organisms so resistant to antibiotics at the molecular level.
    • The data revealed an astonishingly high number of genetic mechanisms making the microorganisms resistant.
    • In some cases, the genetic information encoding resistance was capable of being shared among other microorganisms.

The need for antimicrobial stewardship

    • Some of the resistance genes were capable of moving from one microorganism to another (mobile resistance genes).
    • Antimicrobial stewardship based on laboratory data is effective especially if done locally, regionally and nationally.

Antimicrobial resistance is everyone’s concern

    • Read more:
      Antimicrobial resistance calls for brainpower of a space agency and campaigning zeal of an NGO

      Fourth, there are things that everyone can do to help bring antibiotic resistance under control.

    • For example, the US Centers for Disease Control and Prevention list five things that everyone should know about drug resistance and 10 activities to protect yourself and your family against resistance.
    • He is affiliated with the International Society for Antimicrobial Chemotherapy.

Precision Fermentation Fuels Growth in Ophthalmic Viscoelastic Devices Market: Opportunities and Key Segments - ResearchAndMarkets.com

Retrieved on: 
Friday, September 15, 2023

This report provides a comprehensive analysis of the Ophthalmic Viscoelastic Devices (OVD) market, highlighting key trends, market dynamics, and valuable insights for stakeholders.

Key Points: 
  • This report provides a comprehensive analysis of the Ophthalmic Viscoelastic Devices (OVD) market, highlighting key trends, market dynamics, and valuable insights for stakeholders.
  • Ophthalmic viscoelastic devices, commonly known as OVDs, play a crucial role in intraocular surgeries.
  • Regional Insights: The Asia Pacific region is expected to register the highest CAGR in the precision fermentation ingredients market.
  • Revenue Growth: Drive revenues by identifying market categories and segments offering maximum opportunities for consolidations, investments, and strategic partnerships.

Global Precision Fermentation Ingredients Market: Explosive Growth with 44.0% CAGR, Reaching $36.3 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 15, 2023

The global precision fermentation ingredients market is set for remarkable growth, with an estimated value of USD 2.8 billion in 2023 and a projected increase to USD 36.3 billion by 2030.

Key Points: 
  • The global precision fermentation ingredients market is set for remarkable growth, with an estimated value of USD 2.8 billion in 2023 and a projected increase to USD 36.3 billion by 2030.
  • Precision fermentation, which involves lab-grown ingredients, demands substantial investments in research and development to expedite product commercialization.
  • Rising concerns for animal welfare, environmental sustainability, and the demand for alternative proteins have also fueled the market's momentum for precision fermentation ingredients.
  • Asia Pacific Growth: The Asia Pacific region is expected to exhibit the highest CAGR in the precision fermentation ingredients market.